e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
Xiang Tong, Dongguang Wang, Sitong Liu, Yao Ma, Hong Fan
Source:
Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017
Journal Issue:
January
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Xiang Tong, Dongguang Wang, Sitong Liu, Yao Ma, Hong Fan. Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?. Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The serum YKL-40 is a useful biomarker for asthma
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017
Is CCL18 a potential biomarker of type-2 asthma?
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Mast cells in asthma: biomarker and therapeutic target
Source: Eur Respir J 2016; 47: 1040-1042
Year: 2016
Immunoproteasome function as a potential biomarker for asthma severity and response to therapy
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis?
Source: International Congress 2017 – Rare diseases
Year: 2017
Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Visfatin as a possible serum biomarker in COPD
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019
Are T2 biomarkers of any help in diagnosing asthma?
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020
YKL-40 protein as a marker of asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity
Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020
Year: 2021
Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD
Source: Eur Respir J 2014; 43: 951-953
Year: 2014
Lipocalin-2: a biomarker potentially associated with predisposition to COPD
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
The role of airways 17ß-estradiol as a biomarker of severity in post-menopausal asthma
Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease
Year: 2020
Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies?
Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021
Year: 2022
eNose breathprints as surrogate biomarkers for classifying asthma patients by atopy
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019
Lots of promising targets and biomarkers, but how can we deliver the next generation of severe asthma trials?
Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players?
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept